Fecal Occult Testing Market Report, Industry Overview, Growth Rate and Forecast 2025
According to the IMARC Group, A fecal occult blood test (FOBT) refers to a non-invasive procedure used to detect hidden blood in the feces or stool. Samples are collected using cards and flushable reagent pads. These samples are sent to the labs for testing and diagnosing various medical conditions, such as ulcers, hemorrhoids, diverticulosis, colitis, benign tumors and colon cancer, that cause bleeding in the digestive tract. Fecal occult testing enables quicker medical decisions that lead to enhanced quality of life and a reduced mortality rate.
Request for a free sample copy of this report: https://www.imarcgroup.com/fecal-occult-testing-market/requestsample
The growing focus on integrated health services for improved diagnosis and treatment outcomes, coupled with the rising inclination towards point-of-care diagnostics (POCD), is augmenting the market growth. Furthermore, the increasing geriatric population, who are more prone to various gastrointestinal disorders, is also driving the demand for fecal occult testing. Moreover, the widespread adoption of non-invasive and minimally-invasive (MI) procedures for treating hemorrhoids, colon cancer, ulcers, etc., is further augmenting the market. Apart from this, the emergence of immunochemical fecal occult blood tests (iFOBTs or FITs) for accurate diagnosis of gastrointestinal disorders will further continue to drive the global market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global fecal occult testing market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, test type and end user.
Explore full report with table of contents: https://www.imarcgroup.com/fecal-occult-testing-market
Breakup by Test Type:
- Guaiac FOB Stool Test
- Immuno-FOB Agglutination Test
- Lateral Flow Immuno-FOB Test
- Immuno-FOB ELISA Test
Breakup by End User:
- Hospitals
- Clinical Diagnostic Laboratories
- Physician Office Laboratories
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Biohit Oyj, EDP Biotech Corporation, Eiken Chemical Co. Ltd., Epigenomics AG, Quest Diagnostics Incorporated, Quidel Corporation and Randox Laboratories Ltd.
Browse Related Report
https://www.imarcgroup.com/nucleic-acid-testing-market
https://www.imarcgroup.com/polyvinyl-alcohol-technical-material-market-report
https://www.imarcgroup.com/digestive-health-products-market
https://www.imarcgroup.com/enteral-feeding-devices-market
https://www.imarcgroup.com/light-sensors-market
Contact US: IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
Comments
Post a Comment